American Journal of Cardiology
Volume 105, Issue 8 , Pages 1083-1089 , 15 April 2010

Disparities in Management Patterns and Outcomes of Patients With Non–ST-Elevation Acute Coronary Syndrome With and Without a History of Cerebrovascular Disease

  • Tony C. Lee, MD, MSc

      Affiliations

    • Division of Cardiology, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada
    • ,
  • Shaun G. Goodman, MD, MSc

      Affiliations

    • Division of Cardiology, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada
    • Canadian Heart Research Centre, Toronto, Ontario, Canada
    • Corresponding Author InformationCorresponding author: Tel: (416) 864-5465; fax: (416) 864-5159
    • ,
  • Raymond T. Yan, MD

      Affiliations

    • Division of Cardiology, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada
    • Canadian Heart Research Centre, Toronto, Ontario, Canada
    • ,
  • Francois R. Grondin, MD

      Affiliations

    • Hôtel-Dieu de Lévis, Lévis, Quebec, Canada
    • ,
  • Robert C. Welsh, MD

      Affiliations

    • Mazankowksi Alberta Heart Institute, Edmonton, Alberta, Canada
    • ,
  • Barry Rose, MD

      Affiliations

    • Health Sciences Centre, St. John's, Newfoundland, Canada
    • ,
  • Gabor Gyenes, MD

      Affiliations

    • University of Alberta Hospital, Edmonton, Alberta, Canada
    • ,
  • Rodney H. Zimmerman, MD

      Affiliations

    • Regina General Hospital, University of Saskatchewan, Regina, Saskatchewan, Canada
    • ,
  • Real Brossoit, MD

      Affiliations

    • Centre Hospitalier de Granby, Granby, Quebec, Canada
    • ,
  • Gustavo Saposnik, MD

      Affiliations

    • Stroke Research Unit and Stroke Outcome Research Canada (SORCan), St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada
    • ,
  • John J. Graham, MD

      Affiliations

    • Division of Cardiology, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada
    • ,
  • Andrew T. Yan, MD

      Affiliations

    • Division of Cardiology, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada
    • Canadian Heart Research Centre, Toronto, Ontario, Canada
    • Corresponding Author InformationCorresponding author: Tel: (416) 864-5465; fax: (416) 864-5159
    • ,
  • Canadian Acute Coronary Syndromes I and II, Canadian Global Registry of Acute Coronary Events (GRACE/GRACE2) and the Canadian Registry of Acute Coronary Events (CANRACE) Investigators

Received 23 September 2009 ,Revised 3 December 2009 ,Accepted 3 December 2009.

References 

  1. Ross R. Atherosclerosis—an inflammatory disease. N Engl J Med. 1999;340:115–126
  2. Rothwell PM, Villagra R, Gibson R, Donders RC, Warlow CP. Evidence of a chronic systemic cause of instability of atherosclerotic plaques. Lancet. 2000;355:19–24
  3. Aronow WS, Ahn C. Prevalence of coexistence of coronary artery disease, peripheral arterial disease, and atherothrombotic brain infarction in men and women > or = 62 years of age. Am J Cardiol. 1994;74:64–65
  4. Kallikazaros I, Tsioufis C, Sideris S, Stefanadis C, Toutouzas P. Carotid artery disease as a marker for the presence of severe coronary artery disease in patients evaluated for chest pain. Stroke. 1999;30:1002–1007
  5. Doonan AL, Karha J, Carrigan TP, Bavry AA, Begelman SM, Ellis SG, et al. Presence of carotid and peripheral arterial disease in patients with left main disease. Am J Cardiol. 2007;100:1087–1089
  6. Reicher-Reiss H, Jonas M, Tanne D, Mandelzweig L, Goldbourt U, Shotan A, et al. Prognostic significance of cerebrovascular disease in 11,526 chronic coronary artery disease patients. Am J Cardiol. 1998;82:1532–1535A7
  7. Cotter G, Cannon CP, McCabe CH, Michowitz Y, Kaluski E, Charlesworth A, et al. Prior peripheral arterial disease and cerebrovascular disease are independent predictors of adverse outcome in patients with acute coronary syndromes: are we doing enough? (Results from the Orbofiban in Patients with Unstable Coronary Syndromes-Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 study). Am Heart J. 2003;145:622–627
  8. Mukherjee D, Eagle KA, Kline-Rogers E, Feldman LJ, Juliard JM, Agnelli G, et al. Impact of prior peripheral arterial disease and stroke on outcomes of acute coronary syndromes and effect of evidence-based therapies (from the Global Registry of Acute Coronary Events). Am J Cardiol. 2007;100:1–6
  9. Bhatt DL, Peterson ED, Harrington RA, Ou FS, Cannon CP, Gibson CM, et al. Prior polyvascular disease: risk factor for adverse ischaemic outcomes in acute coronary syndromes. Eur Heart J. 2009;30:1195–1202
  10. Yan AT, Tan M, Fitchett D, Chow CM, Fowlis RA, McAvinue TG, et al. One-year outcome of patients after acute coronary syndromes (from the Canadian Acute Coronary Syndromes Registry). Am J Cardiol. 2004;94:25–29
  11. Granger CB, Goldberg RJ, Dabbous O, Pieper KS, Eagle KA, Cannon CP, et al. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med. 2003;163:2345–2353
  12. Eagle KA, Lim MJ, Dabbous OH, Pieper KS, Goldberg RJ, Van de Werf F, et al. A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. JAMA. 2004;291:2727–2733
  13. Bagnall AJ, Goodman SG, Fox KA, Yan RT, Gore JM, Cheema AN, et al. Influence of age on use of cardiac catheterization and associated outcomes in patients with non-ST-elevation acute coronary syndromes. Am J Cardiol. 2009;103:1530–1536
  14. Bhatt DL, Roe MT, Peterson ED, Li Y, Chen AY, Harrington RA, et al. Utilization of early invasive management strategies for high-risk patients with non–ST-segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative. JAMA. 2004;292:2096–2104
  15. Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001;345:494–502
  16. Mehta SR, Yusuf S, Peters RJ, Bertrand ME, Lewis BS, Natarajan MK, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet. 2001;358:527–533
  17. Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol. 2007;50:e1–e157
  18. Bhatt DL, Flather MD, Hacke W, Berger PB, Black HR, Boden WE, et al. Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial. J Am Coll Cardiol. 2007;49:1982–1988
  19. Saposnik G, Goodman SG, Leiter LA, Yan RT, Fitchett DH, Bayer NH, et al. Applying the evidence: do patients with stroke, coronary artery disease, or both achieve similar treatment goals?. Stroke. 2009;40:1417–1424
  20. Cheng EM, Asch SM, Brook RH, Vassar SD, Jacob EL, Lee ML, et al. Suboptimal control of atherosclerotic disease risk factors after cardiac and cerebrovascular procedures. Stroke. 2007;38:929–934
  21. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143–3421
  22. Khan NA, Hemmelgarn B, Herman RJ, Bell CM, Mahon JL, Leiter LA, et al. The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2—therapy. Can J Cardiol. 2009;25:287–298
  23. Fox KA, Poole-Wilson P, Clayton TC, Henderson RA, Shaw TR, Wheatley DJ, et al. 5-Year outcome of an interventional strategy in non–ST-elevation acute coronary syndrome: the British Heart Foundation RITA randomised trial. Lancet. 2005;366:914–920
  24. Lagerqvist B, Husted S, Kontny F, Stahle E, Swahn E, Wallentin L. 5-Year outcomes in the FRISC-II randomised trial of an invasive versus a non-invasive strategy in non–ST-elevation acute coronary syndrome: a follow-up study. Lancet. 2006;368:998–1004
  25. Bavry AA, Kumbhani DJ, Rassi AN, Bhatt DL, Askari AT. Benefit of early invasive therapy in acute coronary syndromes: a meta-analysis of contemporary randomized clinical trials. J Am Coll Cardiol. 2006;48:1319–1325
  26. Yan AT, Yan RT, Tan M, Eagle KA, Granger CB, Dabbous OH, et al. In-hospital revascularization and one-year outcome of acute coronary syndrome patients stratified by the GRACE risk score. Am J Cardiol. 2005;96:913–916
  27. Mehta SR, Granger CB, Boden WE, Steg PG, Bassand JP, Faxon DP, et al. Early versus delayed invasive intervention in acute coronary syndromes. N Engl J Med. 2009;360:2165–2175
  28. Yan AT, Yan RT, Tan M, Fung A, Cohen EA, Fitchett DH, et al. Management patterns in relation to risk stratification among patients with non-ST elevation acute coronary syndromes. Arch Intern Med. 2007;167:1009–1016
  29. Yan AT, Yan RT, Tan M, Casanova A, Labinaz M, Sridhar K, et al. Risk scores for risk stratification in acute coronary syndromes: useful but simpler is not necessarily better. Eur Heart J. 2007;28:1072–1078
  30. Yan AT, Yan RT, Huynh T, Casanova A, Raimondo FE, Fitchett DH, et al. Understanding physicians' risk stratification of acute coronary syndromes: insights from the Canadian ACS-2 Registry. Arch Intern Med. 2009;169:372–378

 Dr. Yan was supported by a New Investigator Award from the Heart and Stroke Foundation of Canada, Ottawa, Ontario, Canada. The Canadian ACS registries were sponsored by the Canadian Heart Research Centre, Toronto, Ontario, Canada (a federally incorporated not-for-profit academic research organization) and Key Pharmaceuticals, Division of Schering Canada, Inc., Mississauga, Ontario, Canada. GRACE and CANRACE were sponsored by an unrestricted grant from Sanofi-Aventis Canada Inc., Laval, Quebec, Canada and Bristol-Myers Squibb Canada, Montreal, Quebec, Canada.

 The industrial sponsors had no involvement in the study conception or design; collection, analysis, and interpretation of data; writing, review, or approval of the report; or the decision to submit the report for publication.

PII: S0002-9149(09)02833-1

doi: 10.1016/j.amjcard.2009.12.005

American Journal of Cardiology
Volume 105, Issue 8 , Pages 1083-1089 , 15 April 2010

Article Tools

* Image Usage & Resolution